The development of thalassemia-associated osteoporosis (TAO) is mainly influenced by bone marrow expansion, hypogonadism, imbalanced cytokine profiles, and a defective growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis. The gene discussed is GH1; the disease is hypogonadism.